|Articles|May 1, 2012
- BioPharm International-05-01-2013
- Volume 26
- Issue 5
BioPharm International, May 2012 Issue (PDF)
Monoclonal Antibodies : Developing an Alternative Polishing Step
Advertisement
Articles in this issue
almost 13 years ago
Regulatory Convergence Sought for Global Pharma Marketalmost 13 years ago
Measuring Protein Mobility with Electrophoretic Light Scatteringalmost 13 years ago
Should Regulation of Combination Products Become More Centralized in Europe?almost 13 years ago
Data and Systems Managementalmost 13 years ago
Report from Brazilalmost 13 years ago
The Future of Valves and Diaphragms Supplyalmost 13 years ago
Extractables and Leachables: Best Practices to Ensure Patient Safetyalmost 13 years ago
Facility Trends: Modularization and Single Usealmost 13 years ago
New Challenges to the Cleanroom Paradigm for Multi-Product Facilitiesalmost 13 years ago
Process Development and Spiking Studies for Virus Filtration of r-hFSHNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
